Open AccessIs it ethical to enroll a patient in a hepatitis C virus clinical trial when current standard of care is highly effective and safe?
Author(s) -
Rao Vijaya L.,
Daugherty Christopher
Publication year - 2015
Publication title -
clinical liver disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 14
ISSN - 2046-2484
DOI - 10.1002/cld.512
Subject(s) - medicine , adverse effect , clinical trial , ribavirin , regimen , intensive care medicine , hepatitis c , hepatitis c virus , randomized controlled trial , immunology , virus
Watch a video presentation of this article Watch the interview with the author